Related Experiment Video
Updated: Dec 12, 2025

10:10
Assessment of the Acute Inhalation Toxicity of Airborne Particles by Exposing Cultivated Human Lung Cells at the Air-Liquid Interface
Published on: February 23, 2020
7.4K
Permitted Daily Exposure Values: Application Considerations in Toxicological Risk Assessments
Douglas J Ball1, William P Beierschmitt2
1Managing Partner, D&B ChemTox LLC, Southbury, CT, USA.
International Journal of Toxicology
|August 15, 2020
Summary
Permitted daily exposure (PDE) values aid drug safety assessment but have limitations. Toxicologists must analyze all safety data and understand that PDE values address systemic toxicity, not local effects or analytical limits.
Area of Science:
- Pharmaceutical Toxicology
- Drug Safety Assessment
- Risk Management
Background:
- Permitted daily exposure (PDE) values are utilized by toxicologists for qualifying impurities in drug substances and products.
- Understanding the limitations of PDE values is crucial for their effective use in risk assessment.
Purpose of the Study:
- To provide an educational overview of the development and application of PDE values in toxicological risk assessment.
- To highlight the importance of comprehensive safety data analysis and the appropriate selection of toxicity studies for PDE calculation.
Main Methods:
- Review of toxicological principles for impurity qualification.
- Analysis of safety data from proxy impurities to illustrate PDE development.
- Discussion of the scope and limitations of PDE values in drug safety.
Main Results:
- PDE values are derived from comprehensive safety data and appropriate toxicity studies when genotoxicity is not a concern.
- PDE values primarily address systemic toxicity and may not be suitable for local toleration or reproductive endpoints.
- PDE values should not be conflated with analytical limits or acceptable impurity levels.
Conclusions:
- PDE values are valuable tools in drug safety risk assessment when used with a clear understanding of their limitations.
- Proper application requires thorough data evaluation, appropriate study selection, and recognition of PDE scope.
- This primer aims to enhance the effective and appropriate use of PDE values in pharmaceutical safety evaluations.
Related Concept Videos
Toxic Reactions: Overview
1.7K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.7K
Types of Toxins
3.0K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
3.0K
Therapeutic Drug Monitoring: Affecting Factors
107
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
107

